A novel prognostic prediction tool for postoperative recurrence in patients with stage II/III colon cancer.
作者信息
Ma Jian, Yang Burton B
机构信息
Department of Urology, Yantai Yuhuangding Hospital, Affiliated with Qingdao University Medical College, Yantai, 264000, Shandong, P. R. China.
Sunnybrook Research Institute, Toronto, ON, M4N 3M5, Canada.
出版信息
Cancer Commun (Lond). 2019 Oct 1;39(1):52. doi: 10.1186/s40880-019-0397-1.
Abstract
摘要
相似文献
1
A novel prognostic prediction tool for postoperative recurrence in patients with stage II/III colon cancer.一种用于II/III期结肠癌患者术后复发的新型预后预测工具。
Cancer Commun (Lond). 2019 Oct 1;39(1):52. doi: 10.1186/s40880-019-0397-1.
2
A circRNA signature predicts postoperative recurrence in stage II/III colon cancer.环状 RNA 特征可预测 II/III 期结肠癌术后复发。
EMBO Mol Med. 2019 Oct;11(10):e10168. doi: 10.15252/emmm.201810168. Epub 2019 Sep 2.
3
[Prognostic value and initial exploratory research on TNM staging method of tumor deposits in stage III colon cancer].[Ⅲ期结肠癌中肿瘤结节TNM分期方法的预后价值及初步探索性研究]
Zhonghua Wei Chang Wai Ke Za Zhi. 2019 Dec 25;22(12):1152-1158. doi: 10.3760/cma.j.issn.1671-0274.2019.12.010.
4
Stromal VCAN expression as a potential prognostic biomarker for disease recurrence in stage II-III colon cancer.基质VCAN表达作为II-III期结肠癌疾病复发的潜在预后生物标志物。
Carcinogenesis. 2016 Sep;37(9):878-887. doi: 10.1093/carcin/bgw069. Epub 2016 Jun 9.
5
Prognostic and predictive value of a microRNA signature in stage II colon cancer: a microRNA expression analysis.miRNA 标志物在 II 期结肠癌中的预后和预测价值：miRNA 表达分析
Lancet Oncol. 2013 Dec;14(13):1295-306. doi: 10.1016/S1470-2045(13)70491-1. Epub 2013 Nov 13.
6
Real-world study of a novel prognostic scoring system: for a more precise prognostication and better clinical treatment guidance in stages II and III colon cancer.一种新型预后评分系统的真实世界研究：用于更精确地预测II期和III期结肠癌的预后并提供更好的临床治疗指导
Int J Colorectal Dis. 2018 Aug;33(8):1107-1114. doi: 10.1007/s00384-018-3071-1. Epub 2018 May 16.
7
Expression of apoptosis regulating proteins identifies stage II and III colon cancer patients with high risk of recurrence.凋亡调控蛋白的表达可识别 II 期和 III 期结肠癌患者中复发风险高的患者。
J Surg Oncol. 2014 Mar;109(3):255-65. doi: 10.1002/jso.23495. Epub 2013 Nov 19.
8
Validation of the 12-gene colon cancer recurrence score as a predictor of recurrence risk in stage II and III rectal cancer patients.验证 12 基因结肠癌复发评分作为 II 期和 III 期直肠癌患者复发风险的预测指标。
J Natl Cancer Inst. 2014 Sep 26;106(11). doi: 10.1093/jnci/dju269. Print 2014 Nov.
9
[Analysis of prognostic factors after radical resection in 628 patients with stage II or III colon cancer].628例Ⅱ期或Ⅲ期结肠癌患者根治性切除术后的预后因素分析
Zhonghua Zhong Liu Za Zhi. 2013 Mar;35(3):212-6. doi: 10.3760/cma.j.issn.0253-3766.2013.03.011.
10
Detection of carcinoembryonic antigen mRNA in peritoneal lavage by the transcription-reverse transcription concerted method indicates poor prognosis in patients with stage II and III colon cancer.采用转录-逆转录协同法检测腹膜灌洗液中癌胚抗原mRNA表明，II期和III期结肠癌患者预后较差。
Surgery. 2015 Feb;157(2):322-30. doi: 10.1016/j.surg.2014.09.015. Epub 2014 Oct 11.
引用本文的文献
1
Circular RNA in liver cancer research: biogenesis, functions, and roles.肝癌研究中的环状RNA：生物发生、功能及作用
Front Oncol. 2025 Mar 28;15:1523061. doi: 10.3389/fonc.2025.1523061. eCollection 2025.
2
CircHADHA-augmented autophagy suppresses tumor growth of colon cancer by regulating autophagy-related gene miR-361.CircHADHA增强的自噬通过调节自噬相关基因miR-361抑制结肠癌的肿瘤生长。
Front Oncol. 2022 Oct 13;12:937209. doi: 10.3389/fonc.2022.937209. eCollection 2022.
本文引用的文献
1
A circRNA signature predicts postoperative recurrence in stage II/III colon cancer.环状 RNA 特征可预测 II/III 期结肠癌术后复发。
EMBO Mol Med. 2019 Oct;11(10):e10168. doi: 10.15252/emmm.201810168. Epub 2019 Sep 2.
2
The biogenesis, biology and characterization of circular RNAs.环状 RNA 的生物发生、生物学和特征。
Nat Rev Genet. 2019 Nov;20(11):675-691. doi: 10.1038/s41576-019-0158-7. Epub 2019 Aug 8.
3
Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics?中国当前癌症形势：2018 年全球癌症统计数据带来的是好消息还是坏消息？
Cancer Commun (Lond). 2019 Apr 29;39(1):22. doi: 10.1186/s40880-019-0368-6.
4
A peptide encoded by circular form of LINC-PINT suppresses oncogenic transcriptional elongation in glioblastoma.环状 LINC-PINT 编码的肽抑制胶质母细胞瘤中的致癌转录延伸。
Nat Commun. 2018 Oct 26;9(1):4475. doi: 10.1038/s41467-018-06862-2.
5
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018：GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
6
Differential incidence trends of colon and rectal cancers in Hong Kong: an age-period-cohort analysis.香港结肠癌和直肠癌的发病趋势差异：一项年龄-时期-队列分析。
Cancer Commun (Lond). 2018 Jun 28;38(1):42. doi: 10.1186/s40880-018-0311-2.
7
Is there a survival benefit from adjuvant chemotherapy for patients with liver oligometastases from colorectal cancer after curative resection?结直肠癌根治性切除术后肝寡转移患者接受辅助化疗是否有生存获益？
Cancer Commun (Lond). 2018 May 29;38(1):29. doi: 10.1186/s40880-018-0298-8.
8
Enhanced breast cancer progression by mutant p53 is inhibited by the circular RNA circ-Ccnb1.环状 RNA circ-Ccnb1 抑制突变型 p53 增强的乳腺癌进展。
Cell Death Differ. 2018 Dec;25(12):2195-2208. doi: 10.1038/s41418-018-0115-6. Epub 2018 May 23.
9
A circular RNA promotes tumorigenesis by inducing c-myc nuclear translocation.环状 RNA 通过诱导 c-myc 核转位促进肿瘤发生。
Cell Death Differ. 2017 Sep;24(9):1609-1620. doi: 10.1038/cdd.2017.86. Epub 2017 Jun 16.
10
CircRNA: functions and properties of a novel potential biomarker for cancer.环状RNA：一种新型癌症潜在生物标志物的功能与特性
Mol Cancer. 2017 May 23;16(1):94. doi: 10.1186/s12943-017-0663-2.
Zotero 插件